As more states across the United States decriminalize or legalize recreational and medicinal cannabis, concerns about cannabis impairment have been floated, with some of the opinion that the plant’s legalization will bring about increased dangerous driving.
Various studies have been conducted on marijuana and driving while impaired. So far, it has been determined that knowing whether a driver’s ability has been impaired by cannabis is a distinctly different task than determining whether an individual has been driving with too much alcohol in their bloodstream. This is mainly because THC, which is the main active chemical in cannabis, can stay in an individual’s system for weeks. Its presence does not mean that the person recently consumed cannabis.
Cognivue, a company that was bought in 2018 by businessman Tom Golisano, is convinced that its computerized cognitive testing device may be a solution to this issue. The company, which was founded in 2005, designs and develops a proprietary cognitive assessment device that is largely used in medical settings. The device was the first device that measures cognitive impairment to be approved for use by the FDA.
According to company officials, a grant from the NIH’s National Eye Institute helped fund its initial research for the device, which was created after more than a decade of research. Cognivue’s clinical account manager Kristin Weber explained that the device had been clinically validated more than once, noting that the company’s objective is to become validated globally.
Company officials have already scheduled meetings with state legislators to notify them of the device, given that the process of testing its effectiveness is currently ongoing.
Last year, the firm tested the device in Philadelphia on 130 drug-impaired people and have scheduled a clinical test at the Green Lab in Denver, Colorado, in June of this year. Weber stated that the company chose Colorado because the state has had legalized marijuana longer than any other state in the country while the lab that was chosen happens to be the leading consultant for the marijuana industry.
Cognivue hopes that the tests prove the device’s reliability, which would allow law enforcement to begin using them as early as this year. The device has been designed to eliminate biases, such as sociological and physical, that may come with cognitive testing. It tests various traits, including visual and mobile responses.
As intended, the police would need to transport an individual suspected of impairment to the station, before administering the cognitive test. Weber asserted that the company wanted to address public safety issues while also making sure that individuals who are using cannabis responsibly and legally are not punished.
As different jurisdictions consider ways to detect motorists who are driving while intoxicated by cannabis, lots of companies, such as Pac Roots Cannabis Corp. (CSE: PACR) OTCQB: PACRF) (FSE: 4XM), are investing a lot to develop products which will appeal to the most sophisticated of clients.
NOTE TO INVESTORS: The latest news and updates relating to Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) are available in the company’s newsroom at http://cnw.fm/PACR
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.